BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36932231)

  • 1. Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy.
    Yang GM; Tian FY; Shen YW; Yang CY; Yuan H; Li P; Gao ZB
    Acta Pharmacol Sin; 2023 Aug; 44(8):1589-1599. PubMed ID: 36932231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence determinants of subtype-specific actions of KCNQ channel openers.
    Wang AW; Yang R; Kurata HT
    J Physiol; 2017 Feb; 595(3):663-676. PubMed ID: 27506413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retigabine, a Kv7.2/Kv7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations.
    Ihara Y; Tomonoh Y; Deshimaru M; Zhang B; Uchida T; Ishii A; Hirose S
    PLoS One; 2016; 11(2):e0150095. PubMed ID: 26910900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter.
    Nissenkorn A; Kornilov P; Peretz A; Blumkin L; Heimer G; Ben-Zeev B; Attali B
    Epileptic Disord; 2021 Oct; 23(5):695-705. PubMed ID: 34519644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
    Padilla K; Wickenden AD; Gerlach AC; McCormack K
    Neurosci Lett; 2009 Nov; 465(2):138-42. PubMed ID: 19733209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels.
    Zhou P; Yu H; Gu M; Nan FJ; Gao Z; Li M
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8726-31. PubMed ID: 23650395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP
    Ambrosino P; Freri E; Castellotti B; Soldovieri MV; Mosca I; Manocchio L; Gellera C; Canafoglia L; Franceschetti S; Salis B; Iraci N; Miceli F; Ragona F; Granata T; DiFrancesco JC; Taglialatela M
    Mol Neurobiol; 2018 Aug; 55(8):7009-7024. PubMed ID: 29383681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
    Zhang D; Thimmapaya R; Zhang XF; Anderson DJ; Baranowski JL; Scanio M; Perez-Medrano A; Peddi S; Wang Z; Patel JR; DeGoey DA; Gopalakrishnan M; Honore P; Yao BB; Surowy CS
    J Neurosci Methods; 2011 Aug; 200(1):54-62. PubMed ID: 21723881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine.
    Tatulian L; Delmas P; Abogadie FC; Brown DA
    J Neurosci; 2001 Aug; 21(15):5535-45. PubMed ID: 11466425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy.
    Li J; Maghera J; Lamothe SM; Marco EJ; Kurata HT
    Mol Pharmacol; 2020 Sep; 98(3):192-202. PubMed ID: 32580997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.
    Miceli F; Soldovieri MV; Ambrosino P; De Maria M; Migliore M; Migliore R; Taglialatela M
    J Neurosci; 2015 Mar; 35(9):3782-93. PubMed ID: 25740509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits.
    Miceli F; Soldovieri MV; Ambrosino P; Barrese V; Migliore M; Cilio MR; Taglialatela M
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4386-91. PubMed ID: 23440208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible link between KCNQ2- and STXBP1-related encephalopathies: STXBP1 reduces the inhibitory impact of syntaxin-1A on M current.
    Devaux J; Dhifallah S; De Maria M; Stuart-Lopez G; Becq H; Milh M; Molinari F; Aniksztejn L
    Epilepsia; 2017 Dec; 58(12):2073-2084. PubMed ID: 29067685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epilepsy phenotype and response to KCNQ openers in mice harboring the Kcnq2 R207W voltage-sensor mutation.
    Tian F; Cao B; Xu H; Zhan L; Nan F; Li N; Taglialatela M; Gao Z
    Neurobiol Dis; 2022 Nov; 174():105860. PubMed ID: 36113748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC).
    Bassi MT; Balottin U; Panzeri C; Piccinelli P; Castaldo P; Barrese V; Soldovieri MV; Miceli F; Colombo M; Bresolin N; Borgatti R; Taglialatela M
    Neurogenetics; 2005 Dec; 6(4):185-93. PubMed ID: 16235065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A.
    Soldovieri MV; Boutry-Kryza N; Milh M; Doummar D; Heron B; Bourel E; Ambrosino P; Miceli F; De Maria M; Dorison N; Auvin S; Echenne B; Oertel J; Riquet A; Lambert L; Gerard M; Roubergue A; Calender A; Mignot C; Taglialatela M; Lesca G
    Hum Mutat; 2014 Mar; 35(3):356-67. PubMed ID: 24375629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.
    Soldovieri MV; Freri E; Ambrosino P; Rivolta I; Mosca I; Binda A; Murano C; Ragona F; Canafoglia L; Vannicola C; Solazzi R; Granata T; Castellotti B; Messina G; Gellera C; Labalme A; Lesca G; DiFrancesco JC; Taglialatela M
    Pharmacol Res; 2020 Oct; 160():105200. PubMed ID: 32942014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calmodulin orchestrates the heteromeric assembly and the trafficking of KCNQ2/3 (Kv7.2/3) channels in neurons.
    Liu W; Devaux JJ
    Mol Cell Neurosci; 2014 Jan; 58():40-52. PubMed ID: 24333508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Carboxyl Terminus Helix C-D Linker in Regulating KCNQ3 K+ Current Amplitudes by Controlling Channel Trafficking.
    Choveau FS; Zhang J; Bierbower SM; Sharma R; Shapiro MS
    PLoS One; 2015; 10(12):e0145367. PubMed ID: 26692086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.